Metastatic Kidney Cancer Written by Jaime Landman, Jamie Kearns and George Haramis
What is the prognosis of people with metastatic kidney cancer?
Recent studies have shown that patients with metastatic kidney cancer have a 5-year survival rate of 16-32%. However, newer treatments are rapidly becoming available that may show a long-term survival benefit as studies become available. In just the past few years, there have been a number of new medications which never existed before to treat metastatic kidney cancer.
